Hypertension in children and adolescents: An approach to management of complex hyper tension in pediatric patients

Current Hypertension Reports

Volumn 11, Issue 5, 2009, Pages 315-322

  Meyers, Kevin ^a   Falkner, Bonita ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE RECEPTOR ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRILAT; ESMOLOL; FELODIPINE; FENOLDOPAM; HYDRALAZINE; IRBESARTAN; ISRADIPINE; LABETALOL; LACIDIPINE; LERCANIDIPINE; LOSARTAN; MINOXIDIL; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; RAMIPRIL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALSARTAN;

ACUTE KIDNEY FAILURE; ADOLESCENT; AORTA ARCH ANOMALY; AORTA COARCTATION; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE MONITORING; BRADYCARDIA; CAROTID ARTERY DISEASE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DISEASE SEVERITY; DRUG DOSE INCREASE; GLOMERULUS FILTRATION RATE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; MICROALBUMINURIA; MID AORTIC SYNDROME; NEPHRECTOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORTHOPEDIC SURGERY; PARAGANGLIOMA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHEOCHROMOCYTOMA; PROTEINURIA; RECOMMENDED DRUG DOSE; REFLEX TACHYCARDIA; RENAL GRAFT DYSFUNCTION; RENAL REPLACEMENT THERAPY; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; REVIEW; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; STENT; TACHYCARDIA; TREATMENT PLANNING; WHITE COAT HYPERTENSION; XEROSTOMIA; AGE; FEMALE; KIDNEY FAILURE, CHRONIC; MALE; PATHOPHYSIOLOGY; UNITED STATES;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CHILD; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; UNITED STATES;

EID: 70349678615     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0054-1     Document Type: Review

References (54)

1. Hansen ML, Gunn PW, Kaelber DC: Underdiagnosis of hypertension in children and adolescents. JAMA 2007, 298:874-879.
2. McNiece KL, Poffenbarger TS, Turner JL, et al.: Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 2007, 150:640-644, 644.e1.
3. Singhal V, Schwenk WF, Kumar S: Evaluation and management of childhood and adolescent obesity. Mayo Clin Proc 2007, 82:1258-1264.
4. Gidding SS: Measuring children's blood pressure matters. Circulation 2008, 117:3163-3164.
5. National High Blood Pressure Education Program Working Group on Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. NIH publication 05:5267, 2005. Available at http://www.nhlbi.nih.gov/health/ prof/heart/hbp/hbp_ped.pdf. Accessed July 9, 2009.
6. Yoon EY, Davis MM, Rocchini A, et al.: Medical management of children with primary hypertension by pediatric subspecialists. Pediatr Nephrol 2009, 24:147-153.
7. Wühl E, Witte K, Soergel M, et al.: Distribution of 24-h ambulatory blood pressure in children: Normalized reference values and role of body dimensions. J Hypertens 2002, 20:1995-2007.
8. Urbina E, Alpert B, Flynn J, et al.: Ambulatory blood pressure monitoring in children and adolescents: Recommendations for standard assessment: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 2008, 52:433-451.
9. O'Brien E: Is the case for ABPM as a routine investigation in clinical practice not overwhelming? Hypertension 2007, 50:284-286.
10. Lande MB, Meagher CC, Fisher SG, et al.: Left ventricular mass index in children with white coat hypertension. J Pediatr 2008, 153:50-54.
11. Kavey RE, Kveselis DA, Atallah N, Smith FC: White coat hypertension in childhood: Evidence for end-organ effect. J Pediatr 2007, 150:491-497.
12. Flynn JT, Daniels SR: Pharmacologic treatment of hypertension in children and adolescents. J Pediatr 2006, 149:746-754.
13. Shroff R, Roebuck DJ, Gordon I, et al.: Angioplasty for renovascular hypertension in children: 20-year experience. Pediatrics 2006, 118:268-275.
14. Towbin RB, Pelchovitz DJ, Cahill AM, et al.: Cutting balloon angioplasty in children with resistant renal artery stenosis. J Vasc Interv Radiol 2007, 18:663-669.
15. Ing FF, Goldberg B, Siegel DH, et al.: Arterial stents in the management of neurofibromatosis and renovascular hypertension in a pediatric patient: Case report of a new treatment modality. Cardiovasc Intervent Radiol 1995, 18:414-418.
16. Imamura H, Isobe M, Takenaka H, et al.: Successful stenting of bilateral renal artery stenosis due to fibromuscular dysplasia assessed by use of pressure guidewire technique: A case report. Angiology 1998, 49:69-74.
17. Teigen CL, Mitchell SE, Venbrux AC, et al.: Segmental renal artery embolization for treatment of pediatric renovascular hypertension. J Vasc Interv Radiol 1992, 3:111-117.
18. McLaren CA, Roebuck DJ: Interventional radiology for renovascular hypertension in children. Tech Vasc Interv Radiol 2003, 6:150-157.
19. Stanley JC, Criado E, Upchurch GR Jr, et al.: Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J Vasc Surg 2006, 44:1219-1228; discussion 1228-1219.
20. Hager A, Kanz S, Kaemmerer H, et al.: Coarctation Long-term Assessment (COALA): Significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material. J Thorac Cardiovasc Surg 2007, 134:738-745.
21. Senzaki H, Iwamoto Y, Ishido H, et al.: Ventricular-vascular stiffening in patients with repaired coarctation of aorta: Integrated pathophysiology of hypertension. Circulation 2008, 118(14 Suppl):S191-S198.
22. Nakagawa TA, Sartori SC, Morris A, Schneider DS: Intravenous nicardipine for treatment of postcoarctectomy hypertension in children. Pediatr Cardiol 2004, 25:26-30.
23. Rouine-Rapp K, Mello DM, Hanley FL, et al.: Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta. Pediatr Crit Care Med 2003, 4:327-332.
24. Sethna CB, Kaplan BS, Cahill AM, et al.: Idiopathic mid-aortic syndrome in children. Pediatr Nephrol 2008, 23:1135-1142.
25. Flynn JT, Mitsnefes M, Pierce C, et al.: Blood pressure in children with chronic kidney disease: A report from the Chronic Kidney Disease in Children study. Hypertension 2008, 52:631-637.
26. Furth SL, Cole SR, Moxey-Mims M, et al.: Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 2006, 1:1006-1015.
27. Schwartz GJ, Furth SL: Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol 2007, 22):1839-1848.
28. Wühl E, Mehls O, Schaefer F: Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 2004, 66:768-776.
29. Shahinfar S, Cano F, Soffer BA, et al.: A double-blind, dose-response study of losartan in hypertensive children. Am J Hypertens 2005, 18:183-190.
30. Flynn JT, Meyers KE, Neto JP, et al.: Efficacy and safety of the angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years. Hypertension 2008, 52:222-228.
31. von Vigier RO, Zberg PM, Teuffel O, Bianchetti MG: Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease. Eur J Pediatr 2000, 159:590-593.
32. Ellis D, Vats A, Moritz ML, et al.: Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria. J Pediatr 2003, 143:89-97.
33. Ellis D, Moritz ML, Vats A, Janosky JE: Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders. Am J Hypertens 2004, 17:928-935.
34. Simonetti GD, von Vigier RO, Konrad M, et al.: Candesartan cilexetil in children with hypertension or proteinuria: Preliminary data. Pediatr Nephrol 2006, 21:1480-1482.
35. Kaito H, Nozu K, Iijima K, et al.: The effect of aldosterone blockade in patients with Alport syndrome. Pediatr Nephrol 2006, 21:1824-1829.
36. Mitsnefes M, Stablein D: Hypertension in pediatric patients on long-term dialysis: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis 2005, 45:309-315.
37. VanDeVoorde RG, Barletta GM, Chand DH, et al.: Blood pressure control in pediatric hemodialysis: The Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol 2007, 22:547-553.
38. Hadtstein C, Schaefer F: Hypertension in children with chronic kidney disease: Pathophysiology and management. Pediatr Nephrol 2008, 23:363-371.
39. Michael M, Brewer ED, Goldstein SL: Blood volume monitoring to achieve target weight in pediatric hemodialysis patients. Pediatr Nephrol 2004, 19:432-437.
40. Power RE, Calleary JG, Hickey DP: Pre-transplant bilateral native nephrectomy for medically refractory hypertension. Ir Med J 2001, 94:214-216.
41. Hocker B, Weber LT, Feneberg R, et al.: Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine micro emulsion and mycophenolate mofetil. Transplantation 2009, 87:934-941.
42. Wilson AC, Greenbaum LA, Barletta GM, et al.: High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients. Pediatr Transplant 2009 Feb 20 (Epub ahead of print).
43. Mitsnefes MM: Hypertension and end-organ damage in pediatric renal transplantation. Pediatr Transplant 2004, 8:394-399.
44. Dost A, Klinkert C, Kapellen T, et al.: Arterial hypertension determined by ambulatory blood pressure profiles: Contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with type 1 diabetes. Diabetes Care 2008, 31:720-725.
45. Darcan S, Goksen D, Mir S, et al.: Alterations of blood pressure in type 1 diabetic children and adolescents. Pediatr Nephrol 2006, 21:672-676.
46. Raile K, Galler A, Hofer S, et al.: Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: Effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007, 30:2523-2528.
47. Ettinger LM, Freeman K, DiMartino-Nardi JR, Flynn JT: Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus. J Pediatr 2005, 147:67-73.
48. Chiarelli F, Trotta D, Verrotti A, Mohn A: Treatment of hypertension and microalbuminuria in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2002, 3:113-124.
49. Hung CS, Chang LY, Sui HH, et al.: Clinical and laboratory findings at initial diagnosis in pediatric Graves' disease in Taiwan. Acta Paediatr Taiwan 2006, 47:77-82.
50. Zimmerman D: Fetal and neonatal hyperthyroidism. Thyroid 1999, 9:727-733.
51. Pacak K: Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 2007, 92:4069-4079.
52. Dell KM, Kaplan BS: Hypertension with lower extremity traumatic amputation. Clin Pediatr (Phila) 2000, 39:417-419.
53. DeVries WH, Kruse RW: Is there a relationship between hypertension and lower-extremity contracture release in cerebral palsy? Am J Orthop 1998, 27:421-422.
54. Heij HA, Ekkelkamp S, Vos A: Hypertension associated with skeletal traction in children. Eur J Pediatr 1992, 151:543-545.